N/A N=4 Use of a Hyperinsulinemic-hypyglycemic Clamp to Study Hypoglycemia: a Method Development Study
Diabetes
Primary: Peak Epinephrine Levels — 609 pg/mL
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 1 N=7 Study of Quizartinib in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia
Primary: Summary of Best Responses After a Daily Dose of 20 mg or 40 mg in Combination With Standard Chemotherapy to Japanese Participants With Newly Diagnosed Acute Myeloid…
Phase 4 N=40 Improving Post-Operative Pain and Recovery in Gynecologic Surgery
Postoperative Pain · Opioid Use · Acetaminophen
Primary: Postoperative Pain: Standardized Pain Scale — 2.82; 3.18 score on a scale — p=.378
N/A N=29 Low Intensity Focused Ultrasound Pulses (LIFUP) to Modulate Pain
Healthy Adults
Primary: Quantitative Sensory Threshold Temperature Levels (Degrees Celsius) — .51; 1.08 Degrees Celsius
N/A N=70 Carbamazepine for the Treatment of Chronic Post-Traumatic Brain Injury Irritability and Aggression
Traumatic Brain Injury
Primary: Neuropsychiatric Inventory Irritability-Aggression Domains Composite Measure -- Observer — 37.7; 36.7 score on a scale — p=0.60
Phase 4 N=25 Treating Hearing Loss to Improve Mood and Cognition in Older Adults
Hearing Loss · Depression
Primary: Hamilton Rating Score for Depression (HRSD) — 12.04; 13.86 score on a scale
N/A N=60 Evaluation of the Communities of Healing Mentorship/Support Group Program: Assessment of Preliminary Efficacy
Eating Disorder · Anorexia Nervosa · Bulimia Nervosa
Primary: Body Mass Index — 21.9; 20.7; 21.5; 21.9 kg/m2 — p=.80
N/A N=100 Couples Health Project: Couples-based Intervention to Reduce Drug Use and HIV Transmission Risk
Risk Behavior · Drug Use · Sex, Anal
Primary: Illicit Drug Use — 3.36; 0.84; 3.13; 0.73 Days (in the past 30 days) — p=0.08
N/A N=40 Mindfulness for Resilience in Early Life
Adolescent With Early Life Stress · Resilience
Primary: Cortisol Reactivity — -0.21; 0.34; 0.05; -0.08 μg/dL — p=<.05
N/A N=109 Post Extubation Delirium and End-tidal Sevoflurane Concentration
Delirium on Emergence
Primary: Number of Participants With Emergence Delirium (ED) — 5; 23 Participants — p=0.003
Phase 2 N=81 Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
Coronary Artery Disease · Human Immunodeficiency Virus
Primary: Coronary Endothelial Function Measured by Percent Change in Coronary Blood Flow With Exercise (%) at 8 Weeks — 8.1; 13.4 Percent change from rest measurement
Phase 3 N=609 Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)
Gastroesophageal Reflux Disease (GERD)
Primary: Change From Baseline in WHSS at Week 8 — -1.751; -1.814 score on a scale — p=0.5566
N/A N=29 Clinical Performance, Safety and Patient Reported Outcomes of an Active Osseointegrated Steady-State Implant System
Hearing Loss
Primary: Change in Hearing Performance With the Osia 2 System at 3 Months Post-surgery Compared to Preoperative Unaided Condition Assessed Via Audiometric Thresholds — -27.3 db…
N/A N=196 Community Study of Outcome Monitoring for Emotional Disorders in Teens
Depression · Anxiety
Primary: Clinical Global Impression - Improvement (CGI-I) Scores — 2.85; 3.20; 3.02; 2.47 score on a scale — p=.338
N/A N=992 Seroprevalence of SARS-Cov-2 Antibodies in Children
COVID · Corona Virus Infection · Multisystem Inflammatory Syndrome in Children
Primary: Immunoglobulins (G and M) to SARS-Cov2 in Plasma — 4.86; 65.32; 64.17 Titres